¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"high frequency filter"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • interference filter
    °£¼·¿©°ú±â, °£¼·°Å¸£°³, °£¼·ÇÊÅÍ
  • low-pass filter
    ÀúÁÖÆÄÅë°ú¿©°ú±â, ÀúÁÖÆÄÅë°ú°Å¸£°³
  • molecular filter
    ºÐÀÚ¿©°ú±â, ºÐÀڰŸ£°³
  • membrane filter
    ¸·¿©°ú±â, ¸·°Å¸£°³, ¸·ÇÊÅÍ
  • protective mask filter
    ¹æÈ£¸¶½ºÅ©¿©°ú±â
  • sterile filter
    ¼¼±Õ¿©°ú±â, ¼¼±Õ°Å¸£°³
  • suction filter
    ÈíÀο©°ú±â, ÈíÀΰŸ£°³
  • sintered glass filter
    ¼Ò°áÀ¯¸®¿©°ú±â, ¼Ò°áÀ¯¸®ÇÊÅÍ, ¼Ò°áÀ¯¸®°Å¸£°³
  • slow sand filter
    ¿Ï¼Ó¸ð·¡¿©°ú±â, ´À¸°¸ð·¡°Å¸£°³
  • wave filter
    ¿©ÆÄ±â, ÆÄÀå°Å¸£°³
  • wedge filter
    ½û±â¿©°ú±â, ½û±â°Å¸£°³, ½û±âÇÊÅÍ
  • high altitude
    °íÁö-, °í¼Ò-
  • high altitude illness
    °í¼Òº´
  • high altitude polycythemia
    ³ôÀº°÷ÀûÇ÷±¸Áõ°¡Áõ
  • high altitude pulmonary edema
    °íÁö´ëÆóºÎÁ¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diatomaceous earth filter
    ±ÔÁ¶Åä°Å¸£°³
  • filter
    °Å¸£°³, ¿©°ú±â, ÇÊÅÍ
  • flattening filter
    ÆíÆò°Å¸£°³, ÆíÆòÈ­¿©°ú±â
  • interference filter
    °£¼·°Å¸£°³, °£¼·ÇÊÅÍ
  • low-pass filter
    ÀúÅë°ú°Å¸£°³, ÀúÅë°ú¿©°ú±â
  • membrane filter
    ¸·°Å¸£°³, ¸·ÇÊÅÍ
  • molecular filter
    ºÐÀڰŸ£°³
  • protective mask filter
    ¹æÈ£°Å¸£°³, ¹æÈ£ÇÊÅÍ
  • sintered glass filter
    ¼Ò°áÀ¯¸®ÇÊÅÍ, ¼Ò°áÀ¯¸®°Å¸£°³
  • slow sand filter
    ´À¸°¸ð·¡°Å¸£°³, ¿Ï¼Ó¸ð·¡¿©°ú±â
  • sterile filter
    ¼¼±Õ°Å¸£°³
  • suction filter
    ÈíÀΰŸ£°³, ÈíÀο©°ú±â
  • wave filter
    ÆÄÀå°Å¸£°³, ¿©ÆÄ±â
  • wedge filter
    ½û±â°Å¸£°³, ½û±âÇÊÅÍ
  • high power application
    °íÃâ·ÂÀû¿ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • polarizing filter
    Æí±¤ÇÊÅÍ
  • porcelain filter
    ÀÚÁ¦(í¸ð²)°Å¸£°³.
  • protective mask filter
    ¹æÈ£(ËÑÌ´)ÇÊÅÍ.
  • quantitative filter paper
    Á¤·®¿©°úÁö.
  • Frequency distribution
    µµ¼öºÐÆ÷(Óøâ¦ÝÂøÖ)
  • Frequency principle
    µµ¼ö¿øÄ¢(Óøâ¦ê«öÎ)
  • Frequency theory of hearing
    û°¢(ôéÊÆ)ÀÇ Áøµ¿¼ö(òÉÔÑâ¦) Çм³(ùÊàã)
  • Larmor frequency
    ¶ó¸ð Á֯ļö
  • angular frequency
    °¢ Á֯ļö
  • frequency
    ºóµµ, µµ¼ö, Á֯ļö, Áøµ¿¼ö
  • frequency
    ºóµµ(Ë×̬), µµ¼ö(̬Ëà),Á֯ļö, Áøµ¿¼ö.
  • frequency
    Á֯ļö
  • frequency analysis
    Á֯ļöºÐ¼®
  • frequency axis
    Á֯ļö Ãà
  • frequency change
    Á֯ļö º¯È­
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bag filter
    ¹é ÇÊÅÍ.
  • barrier filter
    ¿©°úÇÊÅÍ
  • biological filter
    ÇØ¼® ¾à¸®,»ýÈ­ ¹Ì»ý,±â»ý,Ç÷¾×,¸é¿ª,¹ÙÀÌ»ý¹°ÇÐÀû °Å¸£°³.
  • bouillon filter
    ºÎ¿ë°Å¸£°³, ¿©°úºÎ¿ë, ºÎ¿ë¿©°ú¾×.
  • candle filter
    Ä­µé°Å¸£°³ ¡ì¼¼±Õ(á¬Ð¶)ÀÇ¡í.
  • compensating filter
    º¸»óÇÊÅÍ
  • cut-off filter
    Â÷´Ü ÇÊÅÍ
  • cut-off filter
    Â÷´Ü (ó´Ó¨) ÇÊÅÍ
  • diatomaceous earth filter
    ±ÔÁ¶Åä ¿©°ú±â
  • double layer filter =dual media f.
    ÀÌÁß¿©°ú±â.
  • dual media filter =double layer f.
    ÀÌÁß¹èÁö¿©°ú±â.
  • field flattening filter
    Á¶»ç¿µ¿ª ÆíÆòÈ­¿©°ú±â
  • filter
    ¿©°ú (¿©°ú±â) (ÕëΦ (ÕëΦÐï))
  • filter
    ÇÊÅÍ
  • filter photometer
    ÇÊÅͱ¤µµ°è
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • membrane filter
    ¸·(د)°Å¸£°Ô
  • nitrocellulose filter
    ³ªÀÌÆ®·Î¼¿·ç·Î½º ¿©Áö(æ¤òµ)
  • familial high-density lipoprotein deficiency °¡Á·¼º °í¹Ðµµ ÁöÁú´Ü¹éÁú °áÇÌ (Ê«ðéàõÍÔÚËÓøò·òõ
    Ó±ÛÜòõÌÀù¹)
  • high-density lipoprotein
    °í¹Ðµµ ÁöÁú´Ü¹éÁú(ÍÔÚËÓøò·òõÓ±ÛÜòõ)
  • high-energy bond
    °í(ÍÔ)¿¡³ÊÁö °áÇÕ(Ì¿ùê)
  • high-energy compound
    °í(ÍÔ)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • high-energy ion scattering
    °í(ÍÔ)¿¡³ÊÁö À̿»ê¶õ(ߤկ)
  • high-energy phosphate donor
    °í(ÍÔ)¿¡³ÊÁö ÀÎ»ê°ø¿©ÀÚ(×òß«Íêæ¨í­)
  • high-level promoter
    °íÀ§(ÍÔêÈ)ÇÁ·Î¸ðÅÍ
  • high-lipid lipoprotein
    °íÁöÁú ÁöÁú´Ü¹éÁú(ÍÔò·òõò¢òõÓ±ÛÜòõ)
  • high-mannose glycoproteins
    ´Ù(Òý)¸¸³ë½º ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)
  • high-mannose oligosaccharides
    ´Ù(Òý)¸¸³ë½º °ú´çÁú(ÍûÓØòõ)
  • high-mobility group
    °íÀ̵¿µµ ±º(ÍÔì¹ÔÑÓøÏØ)
  • high-performance liquid chromatography
    °í¼º´É(ÍÔàõÒö) ¾×ü(äûô÷) Å©·Î¸¶Åä±×·¡ÇÇ
  • high-potential iron protein
    °íÀüÀ§(ÍÔï³êÈ) ö´Ü¹éÁú(ôÑÓ±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • high resolution
    °íÇØ»ó(µµ)
  • high resolution computed tomography [=HRCT]
    °íÇØ»óÀü»êÈ­´ÜÃþÃÔ¿µ¼ú
  • high risk group
    °íÀ§Çèµµ±º
  • high signal
    °í½ÅÈ£
  • high signal intensity
    °í½ÅÈ£°­µµ
  • high speed
    °í¼ÓÀÇ
  • high speed core cut biopsy
    °í¼ÓÁ߽ɻý°Ë
  • high velocity signal loss
    °í¼Óµµ½ÅÈ£¼Ò½Ç
  • high voltage radiography
    °í¾ÐÃÔ¿µ¼ú
  • high voltage radiography
    °íÀü¾ÐÃÔ¿µ¼ú
  • HRCT [=high resolution comnputed tomography]
    °íÇØ»óÀü»êÈ­´ÜÃþÃÔ¿µ¼ú
  • paramagnetic high susceptibility
    »óÀÚ¼º°íÀÚÈ­À²
  • pseudodiastole in high intensity proton flow
    °í°­µµ¾çÀÚÀ¯µ¿¿¡¼­ À§À̿ϱâ
  • super high field MR scanner
    ÃʰíÀÚÀåMR½ºÄ³³Ê, ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • ultra high field MR scanner
    ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
HP halogen phosphorus; handicapped person; haptoglobin; hard palate; Harvard pump; health profession(al...
CF calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ...
LFT latex fixation test; latex flocculation test; left fronto-transverse [fetal position]; liver functio...
MF magnetic field; meat free; medium frequency; megafarad; membrane filler; merthiolate-formaldehyde [s...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MF membrane filter
HFJV High Frequency Jet Ventilation
H.F.P.P.V. High Frequency Positive Pressure Ventilation
HFV High Frequency Ventilation
HF High frequency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • characteristic frequency
    ƯÀÌ Á֯ļö, ƯÁ¤ Á֯ļö
  • critical flicker fusion frequency
    ÇѰè ÇÁ¸¯Ä¿ À¶ÇÕÄ¡, ÇѰè ÇÁ¸¯Ä¿ Ä¡
  • cumulation frequency distribution
    ´©Àû µ¾¼ö ºÐÆ÷
  • cutioff frequency
    Â÷´Ü Á֯ļö
  • cyclic frequency
    ÁÖ±â Á֯ļö
  • frequency analysis
    ÁÖÆÄ ¼ö ºÐ¼®
  • frequency change
    ÁÖÆÄ ¼ö º¯È­
  • frequency deafness
    ÀúÁÖÆÄ ³ó, ÀúÁÖÆÄ ±Í¸ÔÀ½
  • frequency distribution
    µµ¼ö ºÐÆ÷
  • frequency encoding
    ÁÖÆÄ ¼ö ºÎȣȭ
  • frequency encoding gradient
    ÁÖÆÄ ¼ö ºÎȣȭ °æ»ç
  • frequency modulation imaging
    ÁÖÆÄ ¼ö º¯Á¶ ¿µ»ó
  • frequency of beam
    À½¼ÓÀÇ Á֯ļö
  • frequency of nystagmus
    ¾È ºóµµ
  • frequency of recombination
    ÀçÁ¶ÇÕ ¼ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
vena-tech ivc filter <radiology> Introduced as LGM (L.G. Medical, France), 1985; FDA aprroval 1991: Vena-Tech, Evanston, IL, 6-leg conical design with 6 stabilizing side bars, biocompatible metal known as Phynox (cobalt,chromium,iron,nickel,moly) Efficacy, recurrent PE: 2-6%, IVC occlusion: 8-24%, migration: 0-12% Advantages, ease of placement, excellent clot trapping efficiency, low profile, lacks ferromagnetic activity: minimal MRI artifacts Disadvantages, incomplete opening (6-19%): decreases clot-trapping efficiency, increased incidence from IJ approach, decreased with rapid deployment, increased IVC thrombosis rates: 8% initial reports; 22-24% on subsequent reports by ultrasound/MRI: 2-19% clinically symptomatic
(12 Dec 1998)
venocaval filter A filter used for interruption of IVC to prevent pulmonary embolism; e.g., Greenfield filter.
Synonym: venocaval filter.
(05 Mar 2000)
Rheinberg filter <equipment> A colour-filter disk to be placed, as a dark field stop would be placed, below the substage condenser.
The central circular area, that is filled with one of the two or three colour filters, should safely subtend the objective aperture. The annular quadrants around this are normally contrasting in colour. This is/are the colour shown by the organisms or other specimen detail against the coloured field. The effect is one kind of optical staining.
(05 Aug 1998)
Greenfield filter A multistrutted spring-styled filter usually placed in the inferior vena cava to prevent venous emboli from reaching the pulmonary circulation from the lower extremity.
(05 Mar 2000)
micropore filter A filter made of a meshwork of cellulose acetate or nitrate and with defined pore size. They can be autoclaved and the smaller pore sizes (0.22m,0.45m) are used for sterilising heat labile materials by filtering out micro organisms. Larger pore size filters are used in setting up Boyden chambers. They are about 150m thick and should be distinguished from Nucleopore filters. Millipore is a trade name for micropore filters.
(18 Nov 1997)
Millipore filter <cell culture, equipment> Trade name for a well known brand of micropore filters.
(12 Jan 1998)
hemming filter <apparatus> A filter placed between two tubes attached to each other, often used with centrifuges to selectively remove a substance of interest from a mixture in one tube and deposit the substance into the other tube.
(09 Oct 1997)
simon nitinol ivc filter <radiology> Introduced 1990; Nitinol Medical Technologies, Woburn, MA. BARD, thermal memory alloy:titanium and nickel;, straightened form at cool temperatures (4-10C), reforms into predetermined filter shape at body temperatures efficacy, recurrent PE: 0 - 4.8%, IVC thrombosis: 7 - 11% (by clinical symptoms), access site thrombosis: 2 - 10% advantages, narrow introducer sheath (9 Fr), largest choice of access: brachial or left CFV approach without difficulty, only mild MRI artifacts disadvantages, IVC thrombosis: symptomatic occlusion rates higher than reported wtih Greenfield or bird's nest filters, caval penetration: 1 - 33%, caudal drop: exact filter location difficult to predict
(12 Dec 1998)
spatial filter <radiobiology> Device consisting of a lens pair and a pinhole aperture stop. Intensity fluctuations over the spatial extent of a laser beam are removed by passing the focused beam through the aperture stop. The pinhole must be placed in a vacuum to prevent air breakdown by the focused beam. These filters are used to counter the effects caused by self-focusing.
(09 Oct 1997)
neutral-density filter <equipment> A light-absorbing filter whose absorption spectrum is moderately flat. Depending on the type, the absorption curve is flat primarily in the visible spectral range, or may extend to varying degrees beyond the visible range. For video microscopy, this is an important point since the absorbance may or may not extend into the near-infrared region where the sensitivity of many video image pickup devices is very high.
(05 Aug 1998)
nitinol filter A vena cava filter made with a metal that springs into shape when warmed to body heat by the blood after catheter insertion.
(05 Mar 2000)
Nucleopore filter Filter of defined pore size made by etching a polycarbonate filter that has been bombarded by neutrons, the extent of etching determining the pore size. Very thin, with neat circular holes going right through the membrane, not a complex meshwork like micropore filters.
(18 Nov 1997)
DNA filter assay <molecular biology> A lab technique used to identify the complementary base sequences of DNA. It involves immobilising the DNA on a filter and putting it in a solution that contains radioactively-labelled probe DNA or RNA molecules.
(09 Oct 1997)
inferior vena cava filter <radiology> Indications: contraindication to anticoagulation, failure of anticoagulation, complication of anticoagulation: haemorrhage or thrombocytopenia, large free-floating IVC/iliac vein thrombus expanded indications: cor pulmonale and DVT/PE, patients with high risk of complications to anticoagulation, metastatic disease, syncope in elderly, prophylactic placement in high-risk trauma patients, spinal cord injury, severe head injury, complex pelvic fractures, multiple long bone fractures, prophylactic placement before hip/knee replacement in patients with prior DVT prophylactic filters remain controversial see also: types of IVC filters
(12 Dec 1998)
titanium greenfield ivc filter <radiology> Advantages: low profile: 14.3 Fr introducer sheath, percutaneous placement, lack of ferromagnetic properties, low recurrent PE rate (3-5%), low IVC thrombosis rate (1-9%), successful placement (97%) disadvantages: maximum caval diameter = 28mm, tilting/leg assymetry, difficult placement from left femoral approach see also: indications
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • broadcasting frequency
    ¹æ¼ÛÁ֯ļö
  • frequency
    ÀÚÁÖ ÀϾ;ºó¹øÇÑ;ºó¹ß
  • frequency band
    Á֯ļö´ë
  • frequency changer
    Á֯ļö º¯È¯±â
  • frequency converter
    Á֯ļö º¯È¯±â
  • frequency distribution
    µµ¼ö ºÐÆ÷
  • frequency modulation
    Á֯ļöº¯Á¶
  • frequency response
    Á֯ļöÀÀ´ä
  • intermediate frequency
    Áß°£Á֯ļö
  • low frequency
    ÀúÁÖÆÄ
  • medium frequency
    Á߯Ä
  • radio frequency
    ¹«¼± Á֯ļö 
  • radio-frequency welding
    °íÁÖÆÄ ¿ëÁ¢
  • reach and frequency
    µµ´Þµµ¿Í µµ´Þ Ƚ¼ö(ÀÏ·ÃÀÇ ±¤°í Ȱµ¿À¸·Î ±× °­°í°¡ ¾î´À Á¤µµ ħÅõ Çߴ°¡¸¦ ÃøÁ¤ÇÒ ¶§ »ç¿ëµÇ´Â µÎ°¡Áö ¿ä¼Ò)
  • relative frequency
    »ó´ëµµ¼ö(ºóµµ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á